Salivary caffeine in Parkinson’s disease

We aimed to investigate salivary caffeine content, caffeine absorption and metabolism in Parkinson’s disease (PD) and verify whether salivary caffeine can be used as a biomarker of PD. We enrolled 98 PD patients and 92 healthy subjects. Caffeine and its major metabolite, paraxanthine, were measured...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Leodori, Giorgio, De Bartolo, Maria Ilenia, Belvisi, Daniele, Ciogli, Alessia, Fabbrini, Andrea, Costanzo, Matteo, Manetto, Simone, Conte, Antonella, Villani, Claudio, Fabbrini, Giovanni, Berardelli, Alfredo
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8110998/
https://ncbi.nlm.nih.gov/pubmed/33972579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-89168-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars